Venetoclax Alone or in Combination Shows Promising Activity in Preclinical Models and Clinical Cases of Relapsed/Refractory North American Adult T-Cell Leukemia Lymphoma
Sign Up to like & getrecommendations! Published in 2024 at "Blood"
DOI: 10.1182/blood-2024-206160
Abstract: Background: North American ATLL (NA-ATLL) is a highly aggressive HTLV-I-associated T-cell malignancy with a dismal prognosis. Venetoclax has shown activity in other T-cell malignancies, alone or in combination with hypomethylating agents (HMA), AZT (Zidovudine) with… read more here.
Keywords: combination; atll cell; cell; atll ... See more keywords